News

SEC Filings

Document Details

Form
Filing Date
September 11, 2023
Document Date
August 9, 2023
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com